Who owns Merck & Co Inc New option?
- CUSIP Number: 58933Y905
Tip: Access positions for across all investors
Analyze quarterly positions in Merck & Co Inc New option with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Merck & Co Inc New option stock
Who bought or sold Merck & Co Inc New option this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Simplex Trading | 940k | $99M | 5% | Dec 2025 |
|
| IMC-Chicago | 911k | $110M | -10% | Mar 2026 |
|
| Group One Trading | 394k | $47M | -19% | Mar 2026 |
|
| Hrt Financial | 79k | $9.6M | 100% | Mar 2026 |
|
| Gladius Capital Management | 61k | $7.3M | 100% | Mar 2026 |
|
| Maven Securities | 30k | $3.1M | -41% | Dec 2025 |
|
| Saxon Interests | 4.3k | $373k | 100% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 750.00 | $7.9M | 100% | Dec 2025 |
|
Who sold out of Merck & Co Inc New option?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 732k | $61M |
| SG Americas Securities | Dec 2025 | 268k | $1.6M |
| CenterStar Asset Management | Dec 2025 | 9.0k | $947k |